Top Markets
Coin of the day
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Rankning i aktier #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Aktiekurs
$3.78
Senast synkroniserad: 2026-08-21
Marknadsvärde
$71.20M
Förändring (1 dag)
2.24%
Förändring (1 år)
-43.37%
Land
FR
Handel MaaT Pharma S.A. (MAAT)

Kategori

Historik för aktiesplit för MaaT Pharma S.A. (MAAT)
Aktien MaaT Pharma S.A. (symbol: MAAT) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 22, 2026.
En MAAT-aktie köpt före Aug 22, 2026 motsvarar nu 0 MAAT-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH